Cargando…

Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma

BACKGROUND: Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio in (18)F-fluorodeoxyglucose positron emission tomography...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauschke, Astrid, Altendorf-Hofmann, Annelore, Brückner, Lukas, Drescher, Robert, Freesmeyer, Martin, Settmacher, Utz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020288/
https://www.ncbi.nlm.nih.gov/pubmed/35451699
http://dx.doi.org/10.1007/s00432-022-04009-x
_version_ 1784908223065620480
author Bauschke, Astrid
Altendorf-Hofmann, Annelore
Brückner, Lukas
Drescher, Robert
Freesmeyer, Martin
Settmacher, Utz
author_facet Bauschke, Astrid
Altendorf-Hofmann, Annelore
Brückner, Lukas
Drescher, Robert
Freesmeyer, Martin
Settmacher, Utz
author_sort Bauschke, Astrid
collection PubMed
description BACKGROUND: Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography of the primary tumor can identify patients outside the Milan criteria with as low recurrence rates as patients inside Milan and thus should be added to the established prognostic factors. METHODS: This retrospective study analyzes 103 consecutive patients who underwent (18)F-fluorodeoxyglucose positron emission tomography/computed tomography before liver transplantation for hepatocellular carcinoma using data of clinical tumor registry. Primary endpoints were overall survival and 10-year cumulative recurrence rates. RESULTS: Tumor to liver standardized uptake value ratio of the primary tumor was statistically significant higher in Milan out tumors, “up-to-seven” out tumors, grade 3 tumors, α- fetoprotein level >400 ng/ml and lesions > 5cm in diameter. Factors with statistically significant influence on the 10- year overall survival in the univariate analysis were Milan, up-to-seven” criteria, number of lesions and pT-category. COX regression analysis did not show independently statistically significant factors for 10-year overall survival. Milan, “up-to-seven” criteria, grade, pV, number of lesions, size of lesion, pT-category, tumor to liver standardized uptake value ratio influenced 10-year cumulative recurrence rates statistically significant. Tumor to liver standardized uptake value ratio, grade and pT-category proved to be independently statistically significant factors for 10-year cumulative recurrence rates. CONCLUSIONS: Our study suggests that tumor to liver standardized uptake value standardized uptake value ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography is an independent prognostic factor in transplanted patients with hepatocellular carcinoma. If we focus on preoperative findings, such as tumor size, tumor number and AFP value adding the information given by TLR of (18)F-FDG PET/CT allows to estimate the risk of tumor recurrence more accurate than the established classifications Milan and UTS. Therefore, it may add valuable information to other preoperative findings, such as tumor size, tumor number and AFP level.
format Online
Article
Text
id pubmed-10020288
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100202882023-03-18 Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma Bauschke, Astrid Altendorf-Hofmann, Annelore Brückner, Lukas Drescher, Robert Freesmeyer, Martin Settmacher, Utz J Cancer Res Clin Oncol Original Article – Clinical Oncology BACKGROUND: Tumor recurrence is the leading cause of death after liver transplantation in patients with hepatocellular carcinoma. There is an ongoing debate as to whether metabolic indices such as tumor to liver standardized uptake value ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography of the primary tumor can identify patients outside the Milan criteria with as low recurrence rates as patients inside Milan and thus should be added to the established prognostic factors. METHODS: This retrospective study analyzes 103 consecutive patients who underwent (18)F-fluorodeoxyglucose positron emission tomography/computed tomography before liver transplantation for hepatocellular carcinoma using data of clinical tumor registry. Primary endpoints were overall survival and 10-year cumulative recurrence rates. RESULTS: Tumor to liver standardized uptake value ratio of the primary tumor was statistically significant higher in Milan out tumors, “up-to-seven” out tumors, grade 3 tumors, α- fetoprotein level >400 ng/ml and lesions > 5cm in diameter. Factors with statistically significant influence on the 10- year overall survival in the univariate analysis were Milan, up-to-seven” criteria, number of lesions and pT-category. COX regression analysis did not show independently statistically significant factors for 10-year overall survival. Milan, “up-to-seven” criteria, grade, pV, number of lesions, size of lesion, pT-category, tumor to liver standardized uptake value ratio influenced 10-year cumulative recurrence rates statistically significant. Tumor to liver standardized uptake value ratio, grade and pT-category proved to be independently statistically significant factors for 10-year cumulative recurrence rates. CONCLUSIONS: Our study suggests that tumor to liver standardized uptake value standardized uptake value ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography is an independent prognostic factor in transplanted patients with hepatocellular carcinoma. If we focus on preoperative findings, such as tumor size, tumor number and AFP value adding the information given by TLR of (18)F-FDG PET/CT allows to estimate the risk of tumor recurrence more accurate than the established classifications Milan and UTS. Therefore, it may add valuable information to other preoperative findings, such as tumor size, tumor number and AFP level. Springer Berlin Heidelberg 2022-04-22 2023 /pmc/articles/PMC10020288/ /pubmed/35451699 http://dx.doi.org/10.1007/s00432-022-04009-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article – Clinical Oncology
Bauschke, Astrid
Altendorf-Hofmann, Annelore
Brückner, Lukas
Drescher, Robert
Freesmeyer, Martin
Settmacher, Utz
Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
title Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
title_full Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
title_fullStr Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
title_full_unstemmed Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
title_short Impact of metabolic indices of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
title_sort impact of metabolic indices of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography on post transplantation recurrence of hepatocellular carcinoma
topic Original Article – Clinical Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020288/
https://www.ncbi.nlm.nih.gov/pubmed/35451699
http://dx.doi.org/10.1007/s00432-022-04009-x
work_keys_str_mv AT bauschkeastrid impactofmetabolicindicesof18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyonposttransplantationrecurrenceofhepatocellularcarcinoma
AT altendorfhofmannannelore impactofmetabolicindicesof18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyonposttransplantationrecurrenceofhepatocellularcarcinoma
AT brucknerlukas impactofmetabolicindicesof18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyonposttransplantationrecurrenceofhepatocellularcarcinoma
AT drescherrobert impactofmetabolicindicesof18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyonposttransplantationrecurrenceofhepatocellularcarcinoma
AT freesmeyermartin impactofmetabolicindicesof18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyonposttransplantationrecurrenceofhepatocellularcarcinoma
AT settmacherutz impactofmetabolicindicesof18ffluorodeoxyglucosepositronemissiontomographycomputedtomographyonposttransplantationrecurrenceofhepatocellularcarcinoma